Figure 4From: Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain Fluroescent labeled cannabidiol (A) was visible within diabetic mouse thalamus 6 hours after delivery, with saline intervention leading to no comparable fluorescence (B). Fluroescent labeled nabilone (C) was also visible within diabetic dorsal spinal cord 6 hours after delivery, with saline intervention leading to no comparable fluorescence (D). Bar = 10 μmBack to article page